Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 FDA deems in vitro data on mutations sufficient to expand cystic fibrosis drug label.

Authors: Scott C Bell; Marcus A Mall; Hector Gutierrez; Milan Macek; Susan Madge; Jane C Davies; Pierre-Régis Burgel; Elizabeth Tullis; Claudio Castaños; Carlo Castellani; Catherine A Byrnes; Fiona Cathcart; Sanjay H Chotirmall; Rebecca Cosgriff; Irmgard Eichler; Isabelle Fajac; Christopher H Goss; Pavel Drevinek; Philip M Farrell; Anna M Gravelle; Trudy Havermans; Nicole Mayer-Hamblett; Nataliya Kashirskaya; Eitan Kerem; Joseph L Mathew; Edward F McKone; Lutz Naehrlich; Samya Z Nasr; Gabriela R Oates; Ciaran O'Neill; Ulrike Pypops; Karen S Raraigh; Steven M Rowe; Kevin W Southern; Sheila Sivam; Anne L Stephenson; Marco Zampoli; Felix Ratjen
Journal: Lancet Respir Med Date: 2019-09-27 Impact factor: 30.700

FDA deems in vitro data on mutations sufficient to expand cystic fibrosis drug label.

1. Cystic fibrosis drug Vertex's latest triumph.

1. Vertex CF data wow Wall Street.

Review 2. Cystic Fibrosis: Emergence of Highly Effective Targeted Therapeutics and Potential Clinical Implications.

Review 3. The future of cystic fibrosis care: a global perspective.

4. Bridging Genomics to Phenomics at Atomic Resolution through Variation Spatial Profiling.

5. Potentiation of ABCA3 lipid transport function by ivacaftor and genistein.

6. Fluorescence assay for simultaneous quantification of CFTR ion-channel function and plasma membrane proximity.